Skip to main content
Clinical Trials/NCT05201768
NCT05201768
Completed
Not Applicable

Determination of Walking, Balance, Fall Risk and Kinesiophobia in Individulas with Alzheimer's Dementation

Kırıkkale University1 site in 1 country41 target enrollmentMarch 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer Disease
Sponsor
Kırıkkale University
Enrollment
41
Locations
1
Primary Endpoint
Age
Status
Completed
Last Updated
last year

Overview

Brief Summary

THE OBJECTIVE OF THE RESEARCHERS IS TO DETERMINE WALKING, BALANCE, FALL RISK AND KINESIOPHOBIA IN INDIVIDUALS WITH ALZHEIMER'S DEMENTATION.

Detailed Description

The gait, balance, fall risks and kinesiophobia of individuals with Alzheimer's Dementia will be evaluated and compared with healthy individuals.

Registry
clinicaltrials.gov
Start Date
March 1, 2022
End Date
November 1, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Kırıkkale University
Responsible Party
Principal Investigator
Principal Investigator

Oguzhan Dogancı

Physiotherapist

Kırıkkale University

Eligibility Criteria

Inclusion Criteria

  • INDEPENDENT walker diagnosed with Alzheimer's Dementia

Exclusion Criteria

  • Having a disability to do physical activity Those who have had an operation in the last 6 months

Outcomes

Primary Outcomes

Age

Time Frame: 5 month

between the ages of 50 and 80

Body Mass Index

Time Frame: 5 month

BMI was recorded in kg/m\^2

Secondary Outcomes

  • Tampa Scale(5 month)
  • The Time Up Go Test(5 month)
  • Mini Mental State Test(5 month)
  • The Gait Speed Measurement Test (GSMT)(5 month)
  • The Tinetti Gait and Balance Test (TGBT)(5 month)
  • Fall Risk Self-Assessment Scale(5 month)

Study Sites (1)

Loading locations...

Similar Trials